Recipient age, donor age and time on dialysis were identified as independent risk variables for uncensored graft loss whereas IL-2 induction treatment, MMF treatment and glomerulonephritis as cause of ESRD were associated with improved uncensored graft survival. Here, IL2 is linked to glomerulonephritis.